CEACAM5 and cholangiocarcinoma: For the clinical diagnosis of CCA, the carbohydrate antigen 19-9 (CA 19-9), carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) are routinely used in the differential diagnosis with hepatocellular carcinoma (HCC) [2,6,13,30].